Viyash Scientific DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.63×	0.64×	0.73×	0.54×	0.89×
	0.85×	0.83×	0.46×	433.70×	3.15×
	12.6%	12.2%	6.1%	−0.0%	−3.1%
	1.10×	1.10×	0.99×	0.89×	0.96×
	1.49×	1.49×	2.08×	2.16×	2.04×
	11.1%	10.7%	4.3%	−4.2%	−16.8%
	9.8%	9.8%	3.2%	−5.3%	−17.4%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

VIYASH₹224.55

Viyash Scientific Ltd.

· Pharma & Health

₹ CrorePeersAARTIDRUGS YATHARTH THYROCARE SUPRIYA STAR SPARC SHILPAMED RUBICONMcap ₹9,809 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.89	0.54	0.73	0.64	0.63
Interest Burden (Pretax/EBIT) ×	3.15	433.70	0.46	0.83	0.85
EBIT Margin %	-3.08	-0.01	6.15	12.25	12.63
Asset Turnover ×	0.96	0.89	0.99	1.10	1.10
Financial Leverage (Assets/Equity) ×	2.04	2.16	2.08	1.49	1.49
ROE (5-step product, year-end total equity) %	-16.82	-4.16	4.28	10.74	11.10
ROE (owners' profit / average owners' equity) %	-17.42	-5.29	3.22	9.81	9.81

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.